145 related articles for article (PubMed ID: 8610991)
1. Active suppression of diabetes after oral administration of insulin is determined by antigen dosage.
Bergerot I; Fabien N; Mayer A; Thivolet C
Ann N Y Acad Sci; 1996 Feb; 778():362-7. PubMed ID: 8610991
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes.
Bergerot I; Fabien N; Maguer V; Thivolet C
J Autoimmun; 1994 Oct; 7(5):655-63. PubMed ID: 7840857
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic oral administration of metabolically active insulin entrapped in isobutylcyanoacrylate nanocapsules reduces the incidence of diabetes in nonobese diabetic mice.
Saï P; Damagé C; Rivereau AS; Hoeltzel A; Gouin E
J Autoimmun; 1996 Dec; 9(6):713-22. PubMed ID: 9115573
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
5. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
Saï P; Rivereau AS
Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
[TBL] [Abstract][Full Text] [Related]
6. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
Bergerot I; Fabien N; Thivolet C
Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
[TBL] [Abstract][Full Text] [Related]
7. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice.
Chaillous L; Darquy S; Maugendre S; Rivereau AS; Reach G; Saï P
Diabetologia; 1996 May; 39(5):523-9. PubMed ID: 8739911
[TBL] [Abstract][Full Text] [Related]
8. Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes.
Ploix C; Bergerot I; Fabien N; Perche S; Moulin V; Thivolet C
Diabetes; 1998 Jan; 47(1):39-44. PubMed ID: 9421372
[TBL] [Abstract][Full Text] [Related]
9. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.
Aspord C; Thivolet C
Clin Exp Immunol; 2002 Nov; 130(2):204-11. PubMed ID: 12390307
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.
Ploix C; Bergerot I; Durand A; Czerkinsky C; Holmgren J; Thivolet C
Diabetes; 1999 Nov; 48(11):2150-6. PubMed ID: 10535448
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
12. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice.
Rohane PW; Shimada A; Kim DT; Edwards CT; Charlton B; Shultz LD; Fathman CG
Diabetes; 1995 May; 44(5):550-4. PubMed ID: 7729614
[TBL] [Abstract][Full Text] [Related]
13. Homing of lymphocytes into islets of Langerhans in prediabetic non-obese diabetic mice is not restricted to autoreactive T cells.
Faveeuw C; Gagnerault MC; Kraal G; Lepault F
Int Immunol; 1995 Dec; 7(12):1905-13. PubMed ID: 8746560
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 (IGF-1) protects NOD mice from insulitis and diabetes.
Bergerot I; Fabien N; Maguer V; Thivolet C
Clin Exp Immunol; 1995 Nov; 102(2):335-40. PubMed ID: 7586687
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte function associated antigen-1, integrin alpha 4, and L-selectin mediate T-cell homing to the pancreas in the model of adoptive transfer of diabetes in NOD mice.
Fabien N; Bergerot I; Orgiazzi J; Thivolet C
Diabetes; 1996 Sep; 45(9):1181-6. PubMed ID: 8772719
[TBL] [Abstract][Full Text] [Related]
16. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
17. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes.
Bergerot I; Ploix C; Petersen J; Moulin V; Rask C; Fabien N; Lindblad M; Mayer A; Czerkinsky C; Holmgren J; Thivolet C
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4610-4. PubMed ID: 9114038
[TBL] [Abstract][Full Text] [Related]
18. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ
Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
[TBL] [Abstract][Full Text] [Related]
19. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
Füchtenbusch M; Larger E; Thebault K; Boitard C
Horm Metab Res; 2005 Feb; 37(2):63-7. PubMed ID: 15778920
[TBL] [Abstract][Full Text] [Related]
20. High density insulin receptor-positive T lymphocytes from nonobese diabetic mice transfer insulitis and diabetes.
McInerney MF; Flynn JC; Goldblatt PJ; Najjar SM; Sherwin RS; Janeway CA
J Immunol; 1996 Oct; 157(8):3716-26. PubMed ID: 8871675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
